Current Edition

The Promise of Artificial Intelligence (AI) and Machine Learning in Clinical Drug Development: Impact in the Field of Cardiac Safety

With recent advances in technology, computer science and informatics, new techniques in medicine became available, and existing tools and measurements were drastically enhanced. Specifically, in the field of cardiac safety, we saw a change in technology and standard practice. Yasmin Kahn and Alexandre Durand-Salmon of Cardiabase – Banook Group, discuss when and how AI-based cardiac monitoring should be used in drug development.